As prostate cancer is the most common type of cancer found in men, the clinical and surgical commitments to treating it are enormous, as well as to be expected given the aging male population. Urologic cryotherapy is one such method for those with organ-confined or minimally-spread prostate cancer. The benefits it offers both patient and surgeon are hugely significant: it is minimally invasive, has a favourable success rate and complication rates, is followed by a short period of recuperation, is repeatable if necessary, and costs considerably less than a radical prostatectomy.
Presenting...